Glycopyrrolate Injection
Product Images NDC 70700-166

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70700-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate-spl-1ml-carton-label (Glycopyrrolate Spl 1ml Carton Label)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL in single-dose 1 mL vials. The label indicates the injection is for intramuscular or intravenous administration and contains benzyl alcohol as a preservative. The product is manufactured for Xiromed LLC. The label includes storage instructions and a barcode.*

FDA Label Image

Glycopyrrolate-spl-1ml-container-label (Glycopyrrolate Spl 1ml Container Label)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a 1 mL single dose vial for intramuscular or intravenous use. Contains benzyl alcohol as a preservative. Manufactured for Xiromed LLC, Florham Park, NJ, with storage instructions at 20° to 25°C (68° to 77°F). The label includes an NDC barcode and space for lot and expiration date information.*

FDA Label Image

Glycopyrrolate-spl-20ml-carton-label (Glycopyrrolate Spl 20ml Carton Label)

Label for Glycopyrrolate Injection, USP, 4 mg/20 mL (0.2 mg/mL) in multiple dose vials. The label warns that it is not for use in newborns and contains benzyl alcohol. The injection is for intramuscular or intravenous use. The labeler is Xiromed LLC, manufacturing in India, with storage instructions at controlled room temperature.*

FDA Label Image

Glycopyrrolate-spl-20ml-container-label (Glycopyrrolate Spl 20ml Container Label)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL (4 mg/20 mL) in a 20 mL multiple dose vial. The label states it is for intramuscular or intravenous administration, contains benzyl alcohol preservative, and is marked not for use in newborns. Manufactured for Xiromed LLC in Florham Park, NJ, with storage instructions included.*

FDA Label Image

Glycopyrrolate-spl-2ml-carton-label (Glycopyrrolate Spl 2ml Carton Label)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) intramuscular and intravenous injection by Xiromed LLC. The label states the product contains benzyl alcohol and is not for use in newborns. It indicates 25 single-dose vials of 2 mL each and includes storage instructions and manufacturer details.*

FDA Label Image

Glycopyrrolate-spl-2ml-container-label (Glycopyrrolate Spl 2ml Container Label)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single dose vial. The label includes storage instructions, manufacturer information for Xiromed LLC, Florham Park, NJ, and indicates the product contains benzyl alcohol for intramuscular or intravenous use. The label also features an NDC barcode and placeholders for lot and expiration dates.*

FDA Label Image

Glycopyrrolate-spl-5ml-carton-label (Glycopyrrolate Spl 5ml Carton Label)

Packaging label for Glycopyrrolate Injection, USP, 1 mg/5 mL (0.2 mg/mL) by Xiromed LLC. The label indicates it is for intramuscular or intravenous use and contains benzyl alcohol. It specifies "Not for use in newborns" and includes storage instructions. The package is for 25 multiple dose vials of 5 mL each. Manufacturer location and barcode are also shown.*

FDA Label Image

Glycopyrrolate-spl-5ml-container-label (Glycopyrrolate Spl 5ml Container Label)

Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) in a 5 mL multiple-dose vial label. The label indicates intramuscular or intravenous use and contains benzyl alcohol as a preservative. It is manufactured for Xiromed LLC with storage instructions and usual dosage references included.*

FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

Chemical structure of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight 398.33. The structure includes a quaternary ammonium group and a bromide ion (Br-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.